MedTrace Logo

Identification of Breath Biomarkers in Head and Neck Squamous Cell Carcinoma

NCT02156180 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2015-04-22

No results posted yet for this study

Summary

In this study the Investigators aim to determine specific volatile compounds present in breath samples of patients with oral cavity or oropharyngeal squamous cell carcinoma before and after tumour resection or before and after chemotherapy +/- radiotherapy using gas chromotography-mass spectrometry. The Investigators hypothesize that study participants with a tumour will display a distinct set of volatile organic compounds than can serve as potential cancer biomarkers.

Conditions

  • Oral Cavity Squamous Cell Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma

Sponsors & Collaborators

  • Princess Alexandra Hospital, Brisbane, Australia

    collaborator OTHER

  • Queensland Health Forensic and Scientific Services

    collaborator UNKNOWN

  • Queensland Centre of Excellence for Head and Neck Cancer

    lead OTHER

Principal Investigators

  • Jae Lim, Dr · Princess Alexandra Hospital

  • Ben Panizza, Assoc Prof · Princess Alexandra Hospital

  • Vince Alberts, Mr · Queensland Health Forensic and Scientific Services

  • Jeff Herse, Mr · Queensland Health Forensic and Scientific Services

  • David Pass, Mr · Queensland Health Forensic and Scientific Services

  • Nigel Brown, Dr · Princess Alexandra Hospital

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2015-04-30
Completion
2015-04-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02156180 on ClinicalTrials.gov